Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. I do most of my research work in the area ...

A new study from Karolinska Institutet suggests that a lower-dose drug called endoxifen may offer a safer and more comfortable option for women who need treatment to reduce their risk of breast cancer ...

A study has found promising results with the breast cancer prevention drug (Z)-endoxifen. The drug reduced breast density ...

Adults with this type of breast cancer are eligible for a randomized, open-label, phase 3 National Cancer Institute (NCI)–supported study testing whether anthracycline-free, shorter chemoimmunotherapy ...

Antibody drug conjugates (ADCs) — a class of targeted medications that combine monoclonal antibodies with cytotoxic payloads — are rapidly changing the treatment landscape for patients with metastatic ...

GLP-1 receptor agonists may help improve outcomes among women with breast cancer and chronic cardiometabolic diseases, ...

Macro-Mediterranean diets for patients with high-risk breast cancer recurrence found no overall reduction, but women who adhered more closely to the diet showed potential benefit. Breast cancer ...

In HER2-positive early breast cancer, Kadcyla shows sustained improvement in both invasive disease-free survival and overall survival versus Herceptin. Among patients with HER2-positive early breast ...

WEIGHT loss jabs may boost your odds against breast cancer and lower the risk of death by up to 65 per cent. The blockbuster ...

Kisqali plus NSAI improved iDFS, DDFS, RFS, and DRFS in stage 2/3 HR-positive, HER2-negative early breast cancer across menopausal status and age. Premenopausal patients showed higher absolute benefit ...

A sweeping global review shows that the Mediterranean diet significantly reduces breast cancer risk in postmenopausal women, with Asian populations seeing the strongest effects, highlighting the ...